Axa Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.85 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.58 M
- Revenue Growth 10.50%
- Profit Growth 11.38%
- Ebitda -43.53%
- Net Worth 8.46%
- Total Assets 31.34%
About Axa Life Sciences
Axa Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 September 2014 and has a history of Ten years and five months. Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.85 M.
The company currently has active open charges totaling ₹0.58 M.
Sirisha Talluri and Anvesh Garidepalli serve as directors at the Company.
Company Details
-
Location
Krishna, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U36912AP2014PTC095356
-
Company No.
095356
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Sep 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Axa Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sirisha Talluri
|
Director | 19-Sep-2014 | Current |
|
Anvesh Garidepalli
|
Director | 19-Sep-2014 | Current |
Financial Performance of Axa Life Sciences.
Axa Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.5% increase. The company also saw a substantial improvement in profitability, with a 11.38% increase in profit. The company's net worth moved up by a moderate rise of 8.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Axa Life Sciences?
In 2023, Axa Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.58 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jun 2023 | Hdfc Bank Limited | ₹0.58 M | Open |
How Many Employees Work at Axa Life Sciences?
Unlock and access historical data on people associated with Axa Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Axa Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axa Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
